MLYS Reports $656.6M Cash, $132M R&D, FDA Accepts Lorundrostat NDA, PDUFA Dec 22 2026
Mineralys Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $31.11
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS